Results 41 to 50 of about 1,252,032 (285)

The Role of Tumour Budding as a Prognostic Factor in Primary Invasive Ductal Carcinoma of Breast

Online Journal of Health & Allied Sciences, 2022
Background: Tumor budding is considered as an essential step in invasion and as a poor prognostic factor in carcinoma.It is used as the main prognostic factor in colon cancer but it is now gaining popularity in other tumor types.
Chandana N, Vijay Shankar S, Amita K
doaj  

Tumor budding in invasive breast carcinoma and its association with clinicopathological parameters: an experience from a tertiary care center in India [PDF]

Korean Journal of Clinical Oncology
Purpose Breast cancer is one of the most common cancers globally, with an increasing incidence rate. It is a heterogeneous disease, and early metastasis remains a challenge.
Asmita Shah, Shaivy Malik, Adil Aziz Khan, Charanjeet Ahluwalia   +3 more
doaj   +1 more source

High tumor budding stratifies breast cancer with metastatic properties. [PDF]

, 2015
Tumor budding refers to single or small cluster of tumor cells detached from the main tumor mass. In colon cancer high tumor budding is associated with positive lymph nodes and worse prognosis.
Pfaltz, Katrin, Claudia Lädrach, Cihoric, Nikola, Lädrach, Claudia, Zlobec, Inti, Inti Zlobec, Salhia, Bodour, Trippel, Mafalda, Mafalda Trippel, Bodour Salhia, André Grogg, Nikola Cihoric, Coya Tapia, Grogg, André, Tapia, Coya, Katrin Pfaltz   +15 more
core   +2 more sources

T-cell infiltrates and tumor budding: promising prognostic factors in the tumor microenvironment of colorectal cancer [PDF]

, 2013
The tumor microenvironment is the battleground of pro- and anti-tumor factors. On the tumor’s side, epithelial–mesenchymal transition (EMT) and tumor budding is the histomorphologic signature of aggressive disease.
Lugli, Alessandro, Koelzer, Viktor H; https://orcid.org/, Kölzer, Viktor H.   +2 more
core   +1 more source

European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and gender

BJS (British Journal of Surgery), EarlyView., 2020
Recommendations for clinical and molecular identification of LS, surgical and endoscopic management of LS‐associated colorectal cancer and preventive measures for cancer were produced. The emphasis was on surgical and gastroenterological aspects of the cancer spectrum.
T. T. Seppälä, A. Latchford, I. Negoi, A. Sampaio Soares, R. Jimenez‐Rodriguez, L. Sánchez‐Guillén, D. G. Evans, N. Ryan, E. J. Crosbie, M. Dominguez‐Valentin, J. Burn, M. Kloor, M. von Knebel Doeberitz, F. J. B. van Duijnhoven, P. Quirke, J. R. Sampson, P. Møller, G. Möslein, on behalf of the European Hereditary Tumour Group (EHTG) and European Society of Coloproctology (ESCP)   +18 more
wiley   +1 more source

A classification based on tumor budding and immune score for patients with hepatocellular carcinoma

OncoImmunology, 2020
Background: The role of immune profiling and tumor budding in hepatocellular carcinoma (HCC) remains largely unknown. This study evaluated the association between tumor budding and lymphocytic infiltration in HCC.
Li Wei, Zhang Delin, Yuan Kefei, Wu Hong, Huang Jiwei, Zhang Yange   +5 more
doaj   +1 more source

Prognostic significance of tumor budding in muscle invasive urothelial carcinomas of the bladder

Urology Research and Practice, 2019
Objective: The aim of this study was to evaluate the prognostic significance of tumor budding in muscle invasive urothelial carcinoma of bladder (MIBC).
Ülkü Küçük, Sümeyye Ekmekçi, Ebru Çakır, Zübeyde Ekin, Batuhan Ergani, Gökhan Rahmi Ekin   +5 more
doaj   +1 more source

Tumor budding and fibrotic focus—proposed grading system for tumor budding in invasive carcinoma no special type of the breast

Virchows Archiv, 2022
AbstractTumor budding grade is a very useful histological prognostic indicator for colorectal cancer patients. Recently, it has been also reported as a significant prognostic indicator in invasive breast carcinoma patients. Our group and others have previously reported that the presence of a fibrotic focus in the tumor is a very useful histological ...
Hiratsuka, Miyuki, Hasebe, Takahiro, Ichinose, Yuki, Sakakibara, Ayaka, Fujimoto, Akihiro, Wakui, Noriko, Shibasaki, Satomi, Hirasaki, Masataka, Yasuda, Masanori, Nukui, Akemi, Shimada, Hiroko, Yokogawa, Hideki, Matsuura, Kazuo, Hojo, Takashi, Osaki, Akihiko, Saeki, Toshiaki   +15 more
openaire   +2 more sources

Improving tumor budding reporting in colorectal cancer: a Delphi consensus study [PDF]

, 2021
Tumor budding is a long-established independent adverse prognostic marker in colorectal cancer, yet methods for its assessment have varied widely. In an effort to standardize its reporting, a group of experts met in Bern, Switzerland, in 2016 to reach ...
Brockmoeller, Scarlet Fiona, Loughrey, M.B., Bokhorst, John Melle, Kirsch, Richard,, Riddell, R., Treanor, Darren,, Haddad, Tariq Sami,, Lugli, Alessandro,, Haddad, T.S., Ristimaki, Ari,, van der Laak, Jeroen, El-Zimaity, H., Loughrey, Maurice B., Haddad, Tariq,, Bokhorst, John-Melle,, El-Zimaity, Hala,, Bokhorst, John-Melle, Simmer, F., Cuatrecasas, Miriam,, Sheahan, K., Kuhlmann, Tine,, Vieth, Michael, Zlobec, I., Nagtegaal, Iris D.,, Vieth, Michael,, Nagtegaal, Iris D, Cathomas, Gieri, Kakar, S., Brockmoeller, Scarlet,, Barresi, V., Nagtegaal, I.D., Aherne, S., Gibbons, D., Vieth, M., Treanor, Darren, Gibbons, David,, Fléjou, J.F., Kakar, Sanjay,, Sheahan, Kieran,, El-Zimaity, Hala, Kakar, Sanjay, Nagtegaal, Iris,, Simmer, Femke, Bokhorst, J.M., Aherne, Susan, Brockmoeller, S.F., Loughrey, Maurice B.,, Lugli, Alessandro, Riddell, Robert,, Cathomas, Gieri,, Simmer, Femke,, Langner, C., van der Laak, Jeroen,, Zlobec, Inti,, Kirsch, Richard, Fléjou, Jean-François, Riddell, Robert, Lugli, A., Brockmoeller, Scarlet Fiona,, Gibbons, David, Sheahan, Kieran, Terris, B., Cuatrecasas, M., Kuhlmann, Tine Plato, Loughrey, Maurice B, Barresi, Valeria,, Barresi, Valeria, Zlobec, Inti, Fléjou, Jean François, Laak, J.A.W.M. van der, Aherne, Susan,, Haddad, Tariq Sami, Kuhlmann, Tine Plato,, Ristimäki, Ari, Kuhlmann, T.P., Cathomas, G., Ristimäki, A., Terris, Benoit,, Langner, Cord,, Kirsch, R., Loughrey, Maurice,, Nagtegaal, Iris D., Terris, Benoît, Treanor, D., Cuatrecasas, Miriam, Langner, Cord, Flejou, Jean-Francois,   +86 more
core   +2 more sources

HtrA3 stromal expression is correlated with tumor budding in stage II colorectal cancer. [PDF]

, 2017
Tumor budding is a well-established adverse prognostic factor in colorectal carcinoma (CRC). It may represent a form of epithelial-to-mesenchymal transition (EMT), although the underlying mechanisms remain unclear. High-temperature requirement A3 (HtrA3)
Erin Kennedy, Naziheh Assarzadegan, Kennedy, Erin, Messenger, David E, Karagiannis, George S, Richard Kirsch, Mahdi Rahimi, Heather Dawson, George S. Karagiannis, Forse, Catherine L, David E. Messenger, Eleftherios P. Diamandis, Dawson, Heather, Brenda O'Connor, Catherine L. Forse, Andrea Grin, O'Connor, Brenda, Riddell, Robert H, Robert H. Riddell, Kirsch, Richard, Diamandis, Eleftherios P, Assarzadegan, Naziheh, Grin, Andrea, Rahimi, Mahdi   +23 more
core   +1 more source